Literature DB >> 17219957

Influence of L-arginine on the expression of eNOS and COX2 in experimental pulmonary thromboembolism.

Jianchu Zhang1, Lei Xia, Xiaoju Zhang, Weibing Yang, Ming Bai.   

Abstract

The influence of L-arginine on endothelial nitric oxide synthase (eNOS) and cyclooxygenase 2 (COX2) was observed in experimental pulmonary thromboembolism and the action mechanism on pulmonary thromboembolism was explored. Wistar rats were randomly divided into control group, model group and treatment group. Pulmonary thromboembolism models were established by auto-blood back transfusion, and L-Arg 100 mg/kg was intraperitoneally injected after successful model preparation. The animals were sacrificed at 3 h, 1 day, 3 days and 7 days after embolism. Plasma NO, TXB2 and 6-Keto-PGFla were detected. The expression of eNOS and COX2 protein and mRNA in pulmonary tissues was detected by immunohistochemistry and RT-PCR respectively. The results showed that pulmonary thrombosis could be seen post pulmonary embolism and inflammatory reaction was significant. Plasma NO was decreased (P<0.01), and the levels of TXB2, 6-Keto-PGF1alpha and T/P ratio were all elevated. The expression of eNOS protein and mRNA in the pulmonary tissue was down-regulated (P<0.05), while that of COX2 protein and mRNA was upregulated (P<0.01). In treatment group, the level of NO was increased, the levels of TXB2 and T/P ratio were decreased, but the level of 6-Keto-PGF1alpha was increased. The expression of eNOS protein and mRNA in pulmonary tissue was upregulated (P<0.05), while that of COX2 protein and mRNA was down-regulated (P<0.05). In conclusion, L-arginine can educe the role of pulmonary tissue protection through up-regulating the expression of intra-pulmonary NOS and down -regulating COX2 in pulmonary thromboembolism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17219957     DOI: 10.1007/s11596-006-0509-4

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  5 in total

1.  L-arginine enhances functional recovery and Ca(2+)-dependent nitric oxide synthase activity after ischemia and reperfusion in the rat heart.

Authors:  Q D Wang; E Morcos; P Wiklund; J Pernow
Journal:  J Cardiovasc Pharmacol       Date:  1997-02       Impact factor: 3.105

2.  Successful treatment of pulmonary hypertension with inhaled nitric oxide after pulmonary embolectomy.

Authors:  Georg Trummer; Michael Berchtold-Herz; Jürgen Martin; Friedhelm Beyersdorf
Journal:  Ann Thorac Surg       Date:  2002-04       Impact factor: 4.330

Review 3.  Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis.

Authors:  Claus Kroegel; Angelika Reissig
Journal:  Respiration       Date:  2003 Jan-Feb       Impact factor: 3.580

4.  l-Arginine attenuates acute pulmonary embolism-induced oxidative stress and pulmonary hypertension.

Authors:  Debora Cristine Souza-Costa; Talita Zerbini; Ingrid Ferreira Metzger; João Batista Teixeira Rocha; Raquel Fernanda Gerlach; Jose Eduardo Tanus-Santos
Journal:  Nitric Oxide       Date:  2004-12-23       Impact factor: 4.427

5.  Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules.

Authors:  T W Wakefield; R M Strieter; C A Wilke; A M Kadell; S K Wrobleski; M D Burdick; R Schmidt; S L Kunkel; L J Greenfield
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-02       Impact factor: 8.311

  5 in total
  2 in total

1.  MicroRNA-146b-3p regulates the development and progression of cerebral infarction with diabetes through RAF1/P38MAPK/COX-2 signaling pathway.

Authors:  Fan Cai; Fang Wu; Jiumei Cao; Xiaonan Chen
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

2.  Inflammatory Factors Induce Thrombosis through the miR-146b-3p/p38MAPK/COX-2 Pathway.

Authors:  Zhengjia Su; Fang Wu
Journal:  Biomed Res Int       Date:  2020-04-01       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.